What should I Know Regarding Pregnancy, Nursing and Administering Erlotinib 150 Mg Tablet Antineoplastic - Protein-Tyrosine Kinase Inhibitors to Children or the Elderly?

If you are PREGNANT

  • Not Recommended: MFR RECOMMENDS CONTRACEPTION DURING THERAPY AND 2 WKS AFTER THERAPY IS COMPLETED

If you are NURSING

  • Absolute Contraindication: INSUFF DATA AVAIL; POT FOR SERIOUS TOXICITY

If you are an adult over 60

  • management or monitoring precaution: General-Dehydration increases risk of renal failure. Monitor electrolytes and renal function.

Giving Erlotinib 150 Mg Tablet Antineoplastic - Protein-Tyrosine Kinase Inhibitors to a child under 12

  • Severe Precaution: No established efficacy in pediatrics in trials for recurrent or refractory ependymoma.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.